Soft Tissue Sarcoma Sts clinical trials

Explore recruiting soft tissue sarcoma sts clinical trials.

Recruiting soft tissue sarcoma sts studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Soft Tissue Sarcoma Sts trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Interest of peri operative CHemotherapy In patients with CINSARC high-risk localized Soft Tissue Sarcoma

France

Therapeutic confirmatory (Phase III) EU CTIS Study details

A phase II study on adjuvant vaccination with dendritic cells loaded with autologous tumor homogenate in resected stage IV rare cancers: neuroendocrine tumors (NET) and soft tissue sarcoma (STS).

Italy

Therapeutic exploratory (Phase II) EU CTIS Study details

A Window of Opportunity (WoO) study evaluating pembrolizumab with or without olaparib in Tertiary Lymphoid Structures (TLS)-positive selected resectable Soft Tissue Sarcoma (STS) followed by adjuvant pembrolizumab (NeoSarc)

France

Therapeutic exploratory (Phase II) EU CTIS Study details

Phase III study comparing Trabectedin (T) versus T plus tTF-NGR to entrap T inside the tumor in patients with metastatic and/or refractory soft tissue sarcoma (STS), Acronym: TRABTRAP

Germany

Therapeutic confirmatory (Phase III) EU CTIS Study details

CIRSARC : PHASE III TRIAL INVESTIGATING BENEFIT OF INTENSIFIED PERI-OPERATIVE CHEMOTHERAPY WITHIN HIGH-RISK CINSARC PATIENTS WITH RESECTABLE SOFT-TISSUE SARCOMAS

France

Therapeutic confirmatory (Phase III) EU CTIS Study details

Phase 1b/2 Study Evaluating the Efficacy and Safety of Risvutatug Rezetecan in Participants With Previously Treated Unresectable Advanced or Metastatic Sarcomas

France

Phase I and Phase II (Integrated)- Other EU CTIS Study details

Soft Tissue Sarcoma Sts trials by city

Soft Tissue Sarcoma Sts in Toronto Soft Tissue Sarcoma Sts in Vancouver Soft Tissue Sarcoma Sts in Montreal Soft Tissue Sarcoma Sts in Calgary Soft Tissue Sarcoma Sts in Edmonton Soft Tissue Sarcoma Sts in Ottawa Soft Tissue Sarcoma Sts in Winnipeg Soft Tissue Sarcoma Sts in Quebec City Soft Tissue Sarcoma Sts in Hamilton Soft Tissue Sarcoma Sts in Kitchener Soft Tissue Sarcoma Sts in London Soft Tissue Sarcoma Sts in Halifax Soft Tissue Sarcoma Sts in New York Soft Tissue Sarcoma Sts in Los Angeles Soft Tissue Sarcoma Sts in Chicago Soft Tissue Sarcoma Sts in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease